Cullinan Therapeutics Inc.

09/16/2024 | Press release | Distributed by Public on 09/16/2024 05:19

Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.